Literature DB >> 28234723

Valued Living and Its Relationship to Medication Adherence in Patients with Bipolar and Comorbid Substance Use Disorders.

Brandon A Gaudiano1, Susan J Wenze, Lauren M Weinstock, Katherine M Tezanos, Ivan W Miller.   

Abstract

Bipolar disorder with comorbid substance abuse is associated with high rates of treatment nonadherence. Adherence interventions developed to date have had mixed effects in this population. Valued living (i.e., the consistency between a patient's personal values and daily actions) represents a potentially useful treatment target that may improve adherence. We investigated the relationship between valued living, medication adherence, symptoms, and functioning in a sample of 39 patients diagnosed with bipolar disorder and a comorbid substance use disorder. Results showed that greater values-action consistency explained a unique amount of variance (R change = 15.2%) in medication adherence even after controlling for symptom severity, functional impairment, and other reported reasons for nonadherence. Drug use and treatment beliefs also predicted nonadherence. Findings suggest that valued living should be investigated further as a potentially malleable treatment target in future adherence intervention research.

Entities:  

Mesh:

Year:  2017        PMID: 28234723      PMCID: PMC5327790          DOI: 10.1097/NMD.0000000000000533

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  12 in total

Review 1.  Effectiveness of interventions to improve medication adherence in bipolar disorder.

Authors:  Marie Crowe; Richard Porter; Maree Inder; Cameron Lacey; Dave Carlyle; Lynere Wilson
Journal:  Aust N Z J Psychiatry       Date:  2012-01-05       Impact factor: 5.744

2.  Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs.

Authors:  Mark S Bauer; Linda McBride; William O Williford; Henry Glick; Bruce Kinosian; Lori Altshuler; Thomas Beresford; Amy M Kilbourne; Martha Sajatovic
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

3.  Patients' expectancies, the alliance in pharmacotherapy, and treatment outcomes in bipolar disorder.

Authors:  Brandon A Gaudiano; Ivan W Miller
Journal:  J Consult Clin Psychol       Date:  2006-08

4.  Improving treatment adherence in patients with bipolar disorder and substance abuse: rationale and initial development of a novel psychosocial approach.

Authors:  Brandon A Gaudiano; Lauren M Weinstock; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2011-01       Impact factor: 1.325

5.  Adjunctive psychosocial intervention following Hospital discharge for Patients with bipolar disorder and comorbid substance use: A pilot randomized controlled trial.

Authors:  Susan J Wenze; Brandon A Gaudiano; Lauren M Weinstock; Katherine M Tezanos; Ivan W Miller
Journal:  Psychiatry Res       Date:  2015-06-15       Impact factor: 3.222

6.  Normative data for the 12 item WHO Disability Assessment Schedule 2.0.

Authors:  Gavin Andrews; Alice Kemp; Matthew Sunderland; Michael Von Korff; Tevik Bedirhan Ustun
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

7.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

8.  The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity.

Authors:  E G Altman; D R Hedeker; P G Janicak; J L Peterson; J M Davis
Journal:  Biol Psychiatry       Date:  1994-07-15       Impact factor: 13.382

9.  Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Gary Epstein-Lubow; Katherine Tezanos; Cintly E Celis-Dehoyos; Ivan W Miller
Journal:  Psychiatry Res       Date:  2014-02-01       Impact factor: 3.222

10.  Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.

Authors:  Diego Novick; William Montgomery; Tamas Treuer; Jaume Aguado; Susanne Kraemer; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2015-08-05       Impact factor: 3.630

View more
  2 in total

1.  Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis.

Authors:  Louise Foley; James Larkin; Richard Lombard-Vance; Andrew W Murphy; Lisa Hynes; Emer Galvin; Gerard J Molloy
Journal:  BMJ Open       Date:  2021-09-02       Impact factor: 3.006

2.  The prevalence and clinical correlates of medical disorders comorbidities in patients with bipolar disorder.

Authors:  Zhonggang Wang; Tao Li; Shuhua Li; Kunkun Li; Xianfei Jiang; Chen Wei; Lei Yang; Haiyan Cao; Shen Li; Jie Li
Journal:  BMC Psychiatry       Date:  2022-03-10       Impact factor: 4.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.